| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects (NCT06635226) | IlDong Pharmaceutical Co Ltd | 2024-11-13 |
| Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects (NCT06063291) | IlDong Pharmaceutical Co Ltd | 2023-11-20 |
| Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of ID120040002 in Healthy Volunteers (NCT05663879) | IlDong Pharmaceutical Co Ltd | 2022-12-07 |
| Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects (NCT05604287) | IlDong Pharmaceutical Co Ltd | 2022-10-10 |
| To Evaluate the Pharmacokinetics and the Safety of ID14009 Compared to Coadministration of ID1805 With ID1803 in Healthy Adult Volunteers (NCT05259020) | IlDong Pharmaceutical Co Ltd | 2022-02-22 |
| IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics (NCT04982705) | IlDong Pharmaceutical Co Ltd | 2021-07-07 |
| Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean (NCT04218162) | IlDong Pharmaceutical Co Ltd | 2020-03-24 |
| Pharmacokinetics of Besifovir in Adults With Normal and Impaired Renal Function (NCT04249908) | IlDong Pharmaceutical Co Ltd | 2020-02-13 |
| To Evaluate the Pharmacokinetic/Pharmacodynamic Interactions and Safety Between ID1801 and ID1803 in Healthy Male Adults (NCT04185090) | IlDong Pharmaceutical Co Ltd | 2020-02-01 |
| Study to Evaluate Pharmacokinetics, Safety, and Tolerability Ildong COL-144 Tablet in Korean Healthy Volunteers (NCT03937648) | IlDong Pharmaceutical Co Ltd | 2019-08-01 |
| Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate (NCT04202536) | IlDong Pharmaceutical Co Ltd | 2019-05-29 |
| Study to Evaluate the Use of RHT-3201 in SCORAD Reduction in Young Patients With Atopic Dermatitis (NCT03907228) | IlDong Pharmaceutical Co Ltd | 2019-03-15 |
| A Food Effect Study of Besifovir in Healthy Subjects (NCT03885778) | IlDong Pharmaceutical Co Ltd | 2019-01-13 |
| Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver (NCT03604016) | IlDong Pharmaceutical Co Ltd | 2018-09-23 |
| A Post-marketing Surveillance to Assess Safety and Efficacy of Telostop Plus Tab. (NCT03648801) | IlDong Pharmaceutical Co Ltd | 2018-09-01 |
| A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/Ezetimibe (NCT03648788) | IlDong Pharmaceutical Co Ltd | 2018-09-01 |